Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
ACADIA Pharmaceuticals Inc. Stock Forecast NASDAQ:ACAD
Price Target and Analyst Ratings
Historical Ratings
| Date | Upside / Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 2022-04-19 | 60.43% | Mizuho | $28.00 $27.00 | Maintains | Neutral |
| 2022-03-16 | 84.19% | Canaccord Genuity | $30.00 $31.00 | Upgrades | Hold Buy |
| 2022-03-10 | 119.85% | Cantor Fitzgerald | $32.00 $37.00 | Maintains | Overweight |
| 2022-03-07 | 42.6% | Goldman Sachs | $27.00 $24.00 | Maintains | Neutral |
| 2022-03-03 | 66.37% | Mizuho | $33.00 $28.00 | Maintains | Neutral |
| 2022-03-01 | 107.96% | JMP Securities | $42.00 $35.00 | Maintains | Market Outperform |
| 2022-02-09 | 113.9% | HC Wainwright & Co. | $18.00 $36.00 | Upgrades | Neutral Buy |
| 2022-01-05 | 78.25% | Citigroup | $30.00 | Upgrades | Neutral Buy |
| 2021-12-22 | 78.25% | Canaccord Genuity | $26.00 $30.00 | Maintains | Hold |
| 2021-12-21 | 149.55% | JMP Securities | $39.00 $42.00 | Maintains | Market Outperform |
| 2021-12-21 | 90.14% | B of A Securities | $28.00 $32.00 | Maintains | Neutral |
| 2021-12-21 | 66.37% | Guggenheim | $28.00 | Downgrades | Buy Neutral |
| 2021-12-21 | 102.02% | RBC Capital | $32.00 $34.00 | Maintains | Outperform |
| 2021-12-21 | 78.25% | Citigroup | $28.00 $30.00 | Maintains | Neutral |
| 2021-12-09 | 36.66% | Oppenheimer | $20.00 $23.00 | Maintains | Perform |
| 2021-12-09 | 131.73% | JMP Securities | $35.00 $39.00 | Maintains | Market Outperform |
| 2021-12-08 | 66.37% | Goldman Sachs | $25.00 $28.00 | Maintains | Neutral |
| 2021-12-07 | 66.37% | Citigroup | $25.00 $28.00 | Maintains | Neutral |
| 2021-12-07 | 131.73% | JMP Securities | $35.00 $39.00 | Maintains | Market Outperform |
| 2021-12-07 | 54.49% | Mizuho | $24.00 $26.00 | Maintains | Neutral |
| 2021-12-07 | 42.6% | Morgan Stanley | $21.00 $24.00 | Maintains | Equal-Weight |
| 2021-12-07 | 36.66% | Oppenheimer | $20.00 $23.00 | Maintains | Perform |
| 2021-11-01 | 36.66% | Guggenheim | $23.00 | Upgrades | Neutral Buy |
| 2021-10-14 | 18.84% | Morgan Stanley | $20.00 | Downgrades | Overweight Equal-Weight |
| 2021-08-05 | 66.37% | SVB Leerink | $31.00 $28.00 | Maintains | Outperform |
| 2021-08-05 | 60.43% | Morgan Stanley | $29.00 $27.00 | Maintains | Overweight |
| 2021-08-05 | 54.49% | Needham | $30.00 $26.00 | Maintains | Buy |
| 2021-06-10 | 72.31% | Berenberg | $29.00 | Initiates Coverage On | Hold |
| 2021-05-12 | 60.43% | Canaccord Genuity | $26.00 $27.00 | Maintains | Hold |
| 2021-05-06 | 72.31% | Morgan Stanley | $28.00 $29.00 | Maintains | Overweight |
| 2021-04-07 | 6.95% | HC Wainwright & Co. | $43.00 $18.00 | Downgrades | Buy Neutral |
| 2021-04-06 | 66.37% | Morgan Stanley | $50.00 $28.00 | Maintains | Overweight |
| 2021-04-06 | 48.54% | Goldman Sachs | $73.00 $25.00 | Downgrades | Buy Neutral |
| 2021-04-06 | 48.54% | Mizuho | $25.00 | Downgrades | Buy Neutral |
| 2021-04-06 | 54.49% | Canaccord Genuity | $40.00 $26.00 | Downgrades | Buy Hold |
| 2021-04-06 | 24.78% | Jefferies | $40.00 $21.00 | Downgrades | Buy Hold |
| 2021-04-05 | 78.25% | Needham | $44.00 $30.00 | Maintains | Buy |
| 2021-03-10 | - | B of A Securities | - | Downgrades | Buy Neutral |
| 2021-03-09 | - | Guggenheim | - | Downgrades | Buy Neutral |
| 2021-03-09 | 60.43% | Stifel | $68.00 $27.00 | Downgrades | Buy Hold |
| 2021-03-09 | 161.44% | Needham | $60.00 $44.00 | Maintains | Buy |
| 2021-03-09 | 137.67% | Canaccord Genuity | $61.00 $40.00 | Maintains | Buy |
| 2021-03-09 | 197.09% | Morgan Stanley | $65.00 $50.00 | Maintains | Overweight |
| 2021-03-09 | 155.5% | HC Wainwright & Co. | $60.00 $43.00 | Maintains | Buy |
| 2021-03-09 | 107.96% | Citigroup | $66.00 $35.00 | Downgrades | Buy Neutral |
| 2021-03-09 | 107.96% | Raymond James | $65.00 $35.00 | Downgrades | Strong Buy Outperform |
| 2021-02-25 | 286.22% | Morgan Stanley | $60.00 $65.00 | Maintains | Overweight |
| 2020-12-16 | 256.51% | Morgan Stanley | $58.00 $60.00 | Maintains | Overweight |
| 2020-12-16 | 309.98% | Mizuho | $69.00 | Initiates Coverage On | Buy |
| 2020-11-16 | 286.22% | Raymond James | $65.00 | Upgrades | Outperform Strong Buy |
| 2020-11-05 | 244.62% | Morgan Stanley | $57.00 $58.00 | Maintains | Overweight |
| 2020-10-13 | 238.68% | Morgan Stanley | $55.00 $57.00 | Maintains | Overweight |
| 2020-08-25 | 286.22% | Raymond James | $65.00 | Initiates Coverage On | Outperform |
| 2020-08-20 | 226.8% | Morgan Stanley | $55.00 | Initiates Coverage On | Overweight |
| 2020-08-06 | 256.51% | Canaccord Genuity | $56.00 $60.00 | Maintains | Buy |
| 2020-08-06 | 208.97% | SVB Leerink | $56.00 $52.00 | Maintains | Outperform |
| 2020-07-21 | 149.55% | Oppenheimer | $53.00 $42.00 | Maintains | Perform |
| 2020-07-21 | 262.45% | Cantor Fitzgerald | $63.00 $61.00 | Maintains | Overweight |
| 2020-07-21 | 226.8% | RBC Capital | $61.00 $55.00 | Maintains | Outperform |
| 2020-07-07 | 321.87% | Stifel | $41.00 $71.00 | Upgrades | Hold Buy |
| 2020-05-27 | 214.91% | Oppenheimer | $48.00 $53.00 | Maintains | Perform |
| 2020-05-08 | 226.8% | JP Morgan | $50.00 $55.00 | Maintains | Overweight |
| 2020-05-08 | 274.33% | Cantor Fitzgerald | $58.00 $63.00 | Reiterates | Overweight |
| 2020-04-16 | 256.51% | Jefferies | $60.00 | Initiates Coverage On | Buy |
| 2020-03-31 | 327.81% | Goldman Sachs | $45.00 $72.00 | Upgrades | Neutral Buy |
| 2020-03-06 | 309.98% | Citigroup | $69.00 | Initiates Coverage On | Buy |
| 2020-03-02 | 96.08% | JP Morgan | $35.00 $33.00 | Maintains | Neutral |
| 2020-02-27 | 345.63% | Cantor Fitzgerald | $70.00 $75.00 | Reiterates | Overweight |
| 2019-12-16 | 256.51% | Guggenheim | $60.00 | Initiates Coverage On | Buy |
| 2019-11-26 | 315.92% | Cantor Fitzgerald | $63.00 $70.00 | Reiterates | Overweight |
| 2019-11-07 | 107.96% | JP Morgan | $33.00 $35.00 | Maintains | Neutral |
| 2019-10-24 | 161.44% | Oppenheimer | $44.00 | Initiates Coverage On | Perform |
| 2019-10-01 | 256.51% | RBC Capital | $60.00 | Initiates Coverage On | Outperform |
| 2019-09-23 | 232.74% | Cantor Fitzgerald | $49.00 $56.00 | Maintains | Overweight |
| 2019-09-13 | 197.09% | SVB Leerink | $21.00 $50.00 | Upgrades | Market Perform Outperform |
| 2019-09-10 | - | Canaccord Genuity | - | Upgrades | Hold Buy |
| 2019-09-09 | 256.51% | Needham | $34.00 $60.00 | Maintains | Buy |
| 2019-09-03 | 66.37% | Stifel | $24.00 $28.00 | Maintains | Hold |
| 2019-08-27 | 137.67% | Cantor Fitzgerald | $30.00 $40.00 | Reiterates | Overweight |
| 2019-05-31 | 155.5% | Raymond James | $40.00 $43.00 | Reiterates | Strong Buy |
ACAD Stock Trend
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.
Given the current short-term trend, the stock is expected to fall -30.01% during the next 3 months and, with a 90% probability hold a price between $10.04 and $15.73 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
WARNING: Trend forecast is still in the development phase and should be used with caution. Some cases might produce unexpected results such as negative prices at the end of the trend.
Data
| Date | Bottom | Mid | Top |
|---|---|---|---|
| 2022-05-23 | $14.18 | $18.25 | $22.32 |
| 2022-05-24 | $14.03 | $18.09 | $22.16 |
| 2022-05-25 | $13.87 | $17.94 | $22.00 |
| 2022-05-26 | $13.71 | $17.78 | $21.85 |
| 2022-05-27 | $13.55 | $17.62 | $21.69 |
| 2022-05-31 | $13.39 | $17.46 | $21.53 |
| 2022-06-01 | $13.24 | $17.30 | $21.37 |
| 2022-06-02 | $13.08 | $17.15 | $21.21 |
| 2022-06-03 | $12.92 | $16.99 | $21.06 |
| 2022-06-06 | $12.76 | $16.83 | $20.90 |
| 2022-06-07 | $12.60 | $16.67 | $20.74 |
| 2022-06-08 | $12.45 | $16.51 | $20.58 |
| 2022-06-09 | $12.29 | $16.36 | $20.42 |
| 2022-06-10 | $12.13 | $16.20 | $20.27 |
| 2022-06-13 | $11.97 | $16.04 | $20.11 |
| 2022-06-14 | $11.81 | $15.88 | $19.95 |
| 2022-06-15 | $11.66 | $15.72 | $19.79 |
| 2022-06-16 | $11.50 | $15.57 | $19.63 |
| 2022-06-17 | $11.34 | $15.41 | $19.48 |
| 2022-06-21 | $11.18 | $15.25 | $19.32 |
| 2022-06-22 | $11.02 | $15.09 | $19.16 |
| 2022-06-23 | $10.86 | $14.93 | $19.00 |
| 2022-06-24 | $10.71 | $14.78 | $18.84 |
| 2022-06-27 | $10.55 | $14.62 | $18.69 |
| 2022-06-28 | $10.39 | $14.46 | $18.53 |
| 2022-06-29 | $10.23 | $14.30 | $18.37 |
| 2022-06-30 | $10.07 | $14.14 | $18.21 |
| 2022-07-01 | $9.92 | $13.99 | $18.05 |
| 2022-07-05 | $9.76 | $13.83 | $17.90 |
| 2022-07-06 | $9.60 | $13.67 | $17.74 |
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. Its lead product candidate, NUPLAZID, has completed the Phase III pivotal trials for the treatment of Parkinsons disease psychosis and the Phase II trial for the treatment of schizophrenia, as well as is in Phase II study for the treatment of Alzh... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
